Imaging3 Inc. is a leading provider of advanced technology medical imaging devices. Founded in 1993 by Dean Janes, the Company has developed a breakthrough medical imaging device. This device produces 3D medical diagnostic images of virtually any part of the human body in real-time. Imaging3 Inc. trades on the OTC Bulletin Board. They have their headquarters in Burbank, California.

The 3D images, instantly constructed in real-time, are useable for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Healthcare workers using Imaging3 devices will be able to instantly view 3D, high-resolution images. The Company intends to use their existing base of operations and channels of distribution to launch their new medical imaging devices business, based on this Imaging3 Technology.

The Dominion Volumetric Imaging Scanner (DVIS) is a patented mobile fluoroscopy technology. This product can produce a

...

Earlier this week, Novavax, Inc. (NVAX) disclosed that its vaccine, which has been developed using its recombinant virus-like particles technology, protected ferrets against the 2009 novel H1N1 virus in pre-clinical studies. (Ferrets are the closest animal to humans when it comes to getting infected with influenza.)   Results showed that ferrets injected with a high dose of the vaccine did not develop flu symptoms and had no detectable virus in respiratory secretions three days after being exposed to H1N1. Subjects injected with a low dose displayed no detectable virus after five days, but those who did not receive the vaccine became ill. The vaccine was produced in less than four weeks using the company’s proprietory virus-like-particle vaccine technology. Traditional influenza vaccines take several months to produce. The company intends to start human testing later this year. However, the candidate will not be of much use in ...

Highlights include Gilead Sciences (GILD), AstraZeneca (AZN), Sanofi-Aventis (SNY) and Genzyme (GENZ).Last week, President Obama nominated Margaret "Peggy" Hamburg, a former New York City Health Commissioner, to lead the U.S. Food and Drug Administration (FDA). Hamburg's appointment must be confirmed by Congress. The president also named Baltimore Health Commissioner Joshua Sharfstein as FDA deputy commissioner.Hamburg earned her M.D. from Harvard Medical School and completed her training at the New York Hospital/Cornell University Medical Center. She did research in neuroscience at Rockefeller University in New York from 1985 to 1986, and in neuropharmacology at the National Institute of Mental Health in Bethesda, Maryland.From 1986 to 1988, she served in the U.S. Office of Disease Prevention and Health Promotion, and from 1989 to 1990 she was assistant director of the National Institute of Allergy and Infectious Diseases at NIH, where her ...

A reader left a link to a long article from the Boston Globe about what a modern depression would look like. My first observation was that it reads a lot like Michael Panzner's book that I was probably the last person to read two years ago. Amusingly it seemed less bleak than when I read most of the same stuff in Panzner's book two years ago because things have deteriorated so much since then. Foreclosures and unemployment are way up and the stock market and GDP are way down. Given that we are much closer to a depression in terms of what is actually happening on the ground it's like there is less ground between here and the scenario spelled out in the article and because of that it seemed less scary. I'm sure there is some ...